Improving Successful Introduction after a Negative Food Challenge Test: How to Achieve the Best Result?


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
07 Sep 2020
Historique:
received: 27 07 2020
revised: 28 08 2020
accepted: 01 09 2020
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 1 4 2021
Statut: epublish

Résumé

Oral food challenges (OFC) confirm or exclude the presence of a food allergy. The outcome can be positive (allergic symptoms), inconclusive, or negative (no symptoms). In the case of a negative OFC, parents and children are advised to introduce the challenged food allergen into their diet. However, previous studies showed difficulties in a successful introduction at home. The aim of this prospective non-randomized intervention study is to evaluate the effect of a new strategy with more guidance regarding the dietary introduction after a negative food challenge test. We compared two cohorts: an historical (retrospective) control group of 157 children, previously described, who did not receive any special advice after a negative OFC, versus a new cohort consisting of 104 children, who were guided according to our new strategy of written introduction schemes, food diaries, and several phone calls. In the historical control group, introduction was successful in 56%, partially successful in 16%, and 28% failed to introduce at home. After introduction of our new strategy, complete introduction was found in 82%, 11% had partially introduced, and only 8% failed to introduce the allergen. In conclusion, comprehensive advice and dietary recommendation after a negative OFC results in an increase in successful home introduction. Therefore, more attention, guidance, and follow-up of children and parents are desirable after a negative OFC.

Identifiants

pubmed: 32906786
pii: nu12092731
doi: 10.3390/nu12092731
pmc: PMC7551318
pii:
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Allergy Clin Immunol. 2004 Nov;114(5):1195-201
pubmed: 15536431
Eur J Pediatr. 2015 Aug;174(8):1093-9
pubmed: 25762026
Pediatr Allergy Immunol. 2014 Oct;25(6):580-5
pubmed: 25200634
Pediatr Clin North Am. 2011 Apr;58(2):327-49, ix
pubmed: 21453805
Immun Inflamm Dis. 2020 Sep;8(3):292-298
pubmed: 32319204
Pediatr Allergy Immunol. 2003 Oct;14(5):378-82
pubmed: 14641608
Pediatr Allergy Immunol. 2017 Aug;28(5):471-477
pubmed: 28557044
Allergy. 2010 Jun 1;65(6):797-8
pubmed: 19886919
Pediatr Allergy Immunol. 2006 Dec;17(8):601-5
pubmed: 17121588
N Engl J Med. 2002 Nov 7;347(19):1535-6
pubmed: 12421906
J Allergy Clin Immunol. 2006 Feb;117(2 Suppl Mini-Primer):S470-5
pubmed: 16455349
J Allergy Clin Immunol. 2007 Sep;120(3):638-46
pubmed: 17628647
Allergy. 2010 Aug;65(8):933-45
pubmed: 20180792
Nutr J. 2013 Feb 08;12:22
pubmed: 23394146
Eur J Pediatr. 2019 Jul;178(7):1113-1117
pubmed: 31127359
Immunol Allergy Clin North Am. 2015 Feb;35(1):45-59
pubmed: 25459576

Auteurs

Joyce Emons (J)

Division Erasmus MC, Department of Pediatrics, Division of Respiratory Medicine and Allergology, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Marije van Gunst (M)

Division Erasmus MC, Department of Pediatrics, Division of Respiratory Medicine and Allergology, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Olivia Liem (O)

Division Erasmus MC, Department of Pediatrics, Division of Respiratory Medicine and Allergology, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Lonneke Landzaat (L)

Division Erasmus MC, Department of Pediatrics, Division of Respiratory Medicine and Allergology, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Nicolette Arends (N)

Division Erasmus MC, Department of Pediatrics, Division of Respiratory Medicine and Allergology, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH